Taking the journey towards comprehensive treatment of SERIOUS DISEASE

OUR THERAPEUTIC PROGRAMS

We are a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases including oncology and obesity.